Long-term Survival of THA After Pelvic and/or Femoral Osteotomy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCentral Hospital, Nancy, France
About this trial
Analyze the long-term clinical and radiological outcomes of total hip arthroplasty (THA) in patients with hip dysplasia treated by pelvic osteotomy, femoral osteotomy, shelf acetabuloplasty, or a combination of these interventions, performed during childhood or early adulthood. The aim is to understand the impact of these early interventions on THA survival and long-term joint function.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients who underwent THA between 1998 and 2010 and had a prior surgical treatment for hip dysplasia (pelvic, femoral osteotomy, shelf acetabuloplasty or combined osteotomy)
Disqualifiers
None
Trial population
Male and female patients, with no age limit, operated in the Centre Chirurgical Emile Gallé, Nancy, France, between 1998 and 2010
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Total hip arthroplasty
Procedure/SurgeryTotal hip arthroplasty
Treatment groups
20 Participants
are divided into 3 treatment groupsGroup A: Pelvic osteotomy or shelf acetabuloplasty1 intervention
Group B: Femoral osteotomy1 intervention
Group C: Combined osteotomy1 intervention
Trial outcomes
Primary outcomes
1
survival
Study of 15 year survival of THA
Time frame
20 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: